Suppr超能文献

肾切除术和普罗地芬在正常血压大鼠急性激肽诱导的低血压后血压稳态中的作用。

The role of nephrectomy and proadifen in blood pressure homeostasis following an acute kinin-induced hypotension in normotensive rats.

作者信息

Holte H R, Berg T

机构信息

Department of Physiology, Medical faculty, University of Oslo, Norway.

出版信息

Br J Pharmacol. 1996 Apr;117(7):1516-20. doi: 10.1111/j.1476-5381.1996.tb15315.x.

Abstract
  1. We have, in the present work, studied the importance of the kidneys and the renal hypotensive agent, medullipin, in modulating the blood pressure (BP) response to bradykinin, as well as their ability to influence the balance between the NO- and the adrenergic systems superimposed on a bradykinin-induced hypotension. 2. The rats were pretreated with the NO-synthase inhibitor, N omega-nitro-L-arginine methyl esther (L-NAME) (0.3 g kg-1), proadifen (50 mg kg-1), an inhibitor of the medullipin-system, and nephrectomy (24 h) (Nx) alone, and L-NAME in combination with proadifen, Nx or phentolamine (2 mg kg-1). Subsequent injections of bradykinin (3, 6, 15, 30 micrograms kg-1) induced an acute hypotensive response. The fall in BP was dose-dependent in all groups (P < 0.01), except in the Nx/L-NAME group. No differences in the fall in BP were observed between the groups. 3. The duration of the hypotensive response was abbreviated after L-NAME-treatment (P < 0.05). Proadifen-treatment and Nx had no significant effect on the duration of the hypotension in control rats or in L-NAME-treated rats. Pretreatment with phentolamine prevented the L-NAME-induced rapid restoration of BP (P < 0.001). 4. In L-NAME-treated rats a transient hypertension followed the bradykinin-induced hypotensive response. This hypertensive response was not observed after Nx or proadifen-treatment alone, and addition of Nx or proadifen to L-NAME treatment did not alter the hypertensive response as compared to L-NAME alone. Phentolamine, however, abolished the L-NAME-induced hypertension (P < 0.05). 5. In conclusion, the present results do not support the involvement of the medullipin-system or other hypotensive systems localized in the kidneys, in modulating and counteracting the compensatory adrenergic response following an acute bradykinin-induced hypotension. A hampering modulating effect of the NO-system on this compensatory adrenergic response was confirmed, indicating a close relationship between these two systems in BP homeostasis.
摘要
  1. 在本研究中,我们探讨了肾脏及肾性降压因子髓质素在调节对缓激肽的血压(BP)反应中的重要性,以及它们在缓激肽诱导的低血压状态下影响一氧化氮(NO)系统和肾上腺素能系统平衡的能力。2. 大鼠分别用一氧化氮合酶抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME)(0.3 g kg⁻¹)、髓质素系统抑制剂普罗地芬(50 mg kg⁻¹)、单纯肾切除术(24小时)(Nx)预处理,以及L-NAME与普罗地芬、Nx或酚妥拉明(2 mg kg⁻¹)联合预处理。随后注射缓激肽(3、6、15、30 μg kg⁻¹)诱导急性低血压反应。除Nx/L-NAME组外,所有组的血压下降均呈剂量依赖性(P < 0.01)。各组间血压下降幅度无差异。3. L-NAME处理后低血压反应的持续时间缩短(P < 0.05)。普罗地芬处理和Nx对对照大鼠或L-NAME处理大鼠的低血压持续时间无显著影响。酚妥拉明预处理可防止L-NAME诱导的血压快速恢复(P < 0.001)。4. 在L-NAME处理的大鼠中,缓激肽诱导的低血压反应后出现短暂性高血压。单独进行Nx或普罗地芬处理后未观察到这种高血压反应,与单独使用L-NAME相比,在L-NAME处理中添加Nx或普罗地芬并未改变高血压反应。然而,酚妥拉明可消除L-NAME诱导的高血压(P < 0.05)。5. 总之,目前的结果不支持髓质素系统或肾脏中其他降压系统参与调节和对抗急性缓激肽诱导的低血压后的代偿性肾上腺素能反应。证实了NO系统对这种代偿性肾上腺素能反应具有阻碍调节作用,表明这两个系统在血压稳态中存在密切关系。

相似文献

本文引用的文献

3
The renomedullary system of blood pressure control.肾髓质血压控制系统。
Am J Med Sci. 1988 Apr;295(4):231-3. doi: 10.1097/00000441-198804000-00002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验